Ad interim recommendations for diagnosing SARS-CoV-2 infection by the IFCC SARS-CoV-2 variants working group

Giuseppe Lippi; Julien Favresse; Michael M. Gromiha; Jeffrey A. Sorelle; Mario Plebani; Brandon M. Henry

doi:10.1515/cclm-2022-0345

Ad interim recommendations for diagnosing SARS-CoV-2 infection by the IFCC SARS-CoV-2 variants working group

Giuseppe Lippi, Julien Favresse, Michael M. Gromiha, Jeffrey A. Sorelle, Mario Plebani, Brandon M. Henry

Research output: Contribution to journal › Article › peer-review

19 Scopus citations

Abstract

This document, endorsed by the IFCC Working Group on SARS-CoV-2 Variants, aims to update previous indications for diagnosing acute SARS-CoV-2 infection, taking into consideration the evidence that has emerged after the origin and spread of new lineages and sub-lineages of the virus characterized by mutated genetics and altered biochemical, biological and clinical characteristics. These indications encompass the use of different diagnostic strategies in specific clinical settings, such as high risk of SARS-CoV-2 infection (symptomatic patients), low risk of SARS-CoV-2 infection (asymptomatic subjects) at hospital admission/contact tracing, testing in asymptomatic subjects, in epidemiologic surveys and/or population screening, along with tentative indications for identification of new lineages and/or sub-lineages of SARS-CoV-2.

Original language	English (US)
Pages (from-to)	975-981
Number of pages	7
Journal	Clinical Chemistry and Laboratory Medicine
Volume	60
Issue number	7
DOIs	https://doi.org/10.1515/cclm-2022-0345
State	Published - Jun 1 2022
Externally published	Yes

Keywords

COVID-19
SARS-CoV-2
diagnosis
sequencing
variants

ASJC Scopus subject areas

Clinical Biochemistry
Biochemistry, medical

Access to Document

10.1515/cclm-2022-0345

Cite this

@article{9e5e9abd9cc2442e824ab0e88cf1f306,

title = "Ad interim recommendations for diagnosing SARS-CoV-2 infection by the IFCC SARS-CoV-2 variants working group",

abstract = "This document, endorsed by the IFCC Working Group on SARS-CoV-2 Variants, aims to update previous indications for diagnosing acute SARS-CoV-2 infection, taking into consideration the evidence that has emerged after the origin and spread of new lineages and sub-lineages of the virus characterized by mutated genetics and altered biochemical, biological and clinical characteristics. These indications encompass the use of different diagnostic strategies in specific clinical settings, such as high risk of SARS-CoV-2 infection (symptomatic patients), low risk of SARS-CoV-2 infection (asymptomatic subjects) at hospital admission/contact tracing, testing in asymptomatic subjects, in epidemiologic surveys and/or population screening, along with tentative indications for identification of new lineages and/or sub-lineages of SARS-CoV-2.",

keywords = "COVID-19, SARS-CoV-2, diagnosis, sequencing, variants",

author = "Giuseppe Lippi and Julien Favresse and Gromiha, {Michael M.} and Sorelle, {Jeffrey A.} and Mario Plebani and Henry, {Brandon M.}",

note = "Publisher Copyright: {\textcopyright} 2022 Walter de Gruyter GmbH, Berlin/Boston.",

year = "2022",

month = jun,

day = "1",

doi = "10.1515/cclm-2022-0345",

language = "English (US)",

volume = "60",

pages = "975--981",

journal = "Clinical Chemistry and Laboratory Medicine",

issn = "1434-6621",

publisher = "Walter de Gruyter GmbH & Co. KG",

number = "7",

}

TY - JOUR

T1 - Ad interim recommendations for diagnosing SARS-CoV-2 infection by the IFCC SARS-CoV-2 variants working group

AU - Lippi, Giuseppe

AU - Favresse, Julien

AU - Gromiha, Michael M.

AU - Sorelle, Jeffrey A.

AU - Plebani, Mario

AU - Henry, Brandon M.

PY - 2022/6/1

Y1 - 2022/6/1

N2 - This document, endorsed by the IFCC Working Group on SARS-CoV-2 Variants, aims to update previous indications for diagnosing acute SARS-CoV-2 infection, taking into consideration the evidence that has emerged after the origin and spread of new lineages and sub-lineages of the virus characterized by mutated genetics and altered biochemical, biological and clinical characteristics. These indications encompass the use of different diagnostic strategies in specific clinical settings, such as high risk of SARS-CoV-2 infection (symptomatic patients), low risk of SARS-CoV-2 infection (asymptomatic subjects) at hospital admission/contact tracing, testing in asymptomatic subjects, in epidemiologic surveys and/or population screening, along with tentative indications for identification of new lineages and/or sub-lineages of SARS-CoV-2.

AB - This document, endorsed by the IFCC Working Group on SARS-CoV-2 Variants, aims to update previous indications for diagnosing acute SARS-CoV-2 infection, taking into consideration the evidence that has emerged after the origin and spread of new lineages and sub-lineages of the virus characterized by mutated genetics and altered biochemical, biological and clinical characteristics. These indications encompass the use of different diagnostic strategies in specific clinical settings, such as high risk of SARS-CoV-2 infection (symptomatic patients), low risk of SARS-CoV-2 infection (asymptomatic subjects) at hospital admission/contact tracing, testing in asymptomatic subjects, in epidemiologic surveys and/or population screening, along with tentative indications for identification of new lineages and/or sub-lineages of SARS-CoV-2.

KW - COVID-19

KW - SARS-CoV-2

KW - diagnosis

KW - sequencing

KW - variants

UR - http://www.scopus.com/inward/record.url?scp=85129199380&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85129199380&partnerID=8YFLogxK

U2 - 10.1515/cclm-2022-0345

DO - 10.1515/cclm-2022-0345

M3 - Article

C2 - 35452576

AN - SCOPUS:85129199380

SN - 1434-6621

VL - 60

SP - 975

EP - 981

JO - Clinical Chemistry and Laboratory Medicine

JF - Clinical Chemistry and Laboratory Medicine

IS - 7

ER -

Ad interim recommendations for diagnosing SARS-CoV-2 infection by the IFCC SARS-CoV-2 variants working group

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this